Brief: Achilles Therapeutics PLC Sees U.S. IPO Of 9.75 Million American Depositary Shares Priced Between $17.00 And $19.00 Per ADS - SEC Filing
March 25 (Reuters) - Achilles Therapeutics PLC ACHL.O :
* ACHILLES THERAPEUTICS PLC SEES U.S. IPO OF 9.75 MILLION
AMERICAN
DEPOSITARY SHARES PRICED BETWEEN $17.00 AND $19.00 PER ADS -
SEC FILING
* ACHILLES THERAPEUTICS PLC - CO OFFERING 9.75 MILLION ADSS
Source text for Eikon: [ID: https://bit.ly/39gaPsb]
Further company coverage: ACHL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Achilles Therapeutics
See all newsBrief: Achilles Therapeutics Announces Sale Of Technology Assets To Astrazeneca
Brief: Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market
Achilles gains on plans to explore strategic options
Brief: Achilles Therapeutics To Discontinue Development Of TIL-Based cNET Therapy
Brief: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement